Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kerstin Malmstrom"'
Autor:
Megan McGratty, John A. Wagner, Rohini Ramakrishnan, Paul N.-A Kotey, Kerstin Malmstrom, Alise S. Reicin, Keith Gottesdiener
Publikováno v:
The Journal of Clinical Pharmacology. 46:917-924
Intravenous lidocaine, a nonspecific Na-channel blocker, was used to assess the dental impaction model for evaluation of neuropathic pain drugs. Sixty patients, experiencing moderate or severe pain after removal of > or = 2 third molars, were randomi
Autor:
Maurice Jove, Alise S. Reicin, Michael H. Bourne, Kerstin Malmstrom, Paul Kotey, Steven M. Rhondeau, G. Lynn Rasmussen, Michelle L. Aversano, Jennifer Ang
Publikováno v:
Anesthesia & Analgesia. 101:1104-1111
In this randomized, double-blind, placebo-controlled, multicenter study we assessed the analgesic effect of etoricoxib (a new cyclooxygenase-2 inhibitor) in patients having had knee or hip replacement surgery. A total of 228 patients with moderate or
Publikováno v:
Current Medical Research and Opinion. 21:141-149
To compare the analgesic effect of single doses of etoricoxib 120 mg, oxycodone/ acetaminophen 10 mg/650 mg and codeine/ acetaminophen 60 mg/600 mg in acute pain using the dental impaction model.In this randomized, double-blind, placebo-controlled, p
Publikováno v:
The Clinical Journal of Pain. 20:147-155
To compare the overall analgesic effect, including time to onset, peak and duration of effect for etoricoxib 120 mg, a new COX-2 selective inhibitor, in patients with acute pain to that of placebo. Naproxen sodium 550 mg and acetaminophen/codeine 600
Publikováno v:
Gynecologic and Obstetric Investigation. 56:65-69
Objective: To determine the efficacy of etoricoxib in the treatment of primary dysmenorrhea. Methods: Seventy-three women were randomly assigned to receive single oral doses of etoricoxib 120 mg, placebo, or naproxen sodium 550 mg at the onset of mod
Autor:
P. H. Ratner, George Philip, S. F. Weinstein, Marie-Pierre Malice, Theodore F. Reiss, Frank C. Hampel, Kerstin Malmstrom, C. F. LaForce
Publikováno v:
Clinical & Experimental Allergy. 32:1020-1028
Summary Background Cysteinyl leukotrienes are important proinflammatory mediators believed to have a role in allergic rhinitis. Objective This multicentre, randomized, double-blind, placebo- and active-controlled trial evaluated the effectiveness and
Autor:
Matilde Sanchez, Ricardo Castro, Albert T. Leung, Kerstin Malmstrom, Gyula Poor, Brian Sarembock, Alberto E. Gallacher, Lisa DeTora, Jennifer Ng, Andre Beaulieu
Publikováno v:
Current Medical Research and Opinion. 18:49-58
To evaluate the efficacy of 12 weeks of treatment with etoricoxib, a selective COX-2 inhibitor, in patients with osteoarthritis (OA) of the knee or hip.In the 12-week placebo- and active comparator-controlled period of a randomized, double-blind stud
Autor:
Paul Chervinsky, Susan Lu, Kerstin Malmstrom, Ji Zhang, Iza Peszek, Michel Laviolette, Jean-Claude Pujet, Theodore F. Reiss
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 160:1862-1868
The primary objective of this study was to determine whether montelukast, an oral leukotriene receptor antagonist, provides additional clinical benefit to the effect of inhaled corticosteroids. A total of 642 patients with chronic asthma (FEV(1) 50 t
Autor:
Kerstin Malmstrom, David J. Chang, Adam B. Polis, David Krupa, Gregory P. Geba, Donald R. Mehlisch, Richard A. Petruschke, Paul J. Desjardins
Publikováno v:
The Clinical journal of pain. 21(3)
To determine the time to onset of analgesia of rofecoxib based on a patient-level meta-analysis of randomized, placebo-controlled, postoperative oral surgery pain studies.A search on MEDLINE and of Merck data on file was conducted to identify studies
Publikováno v:
The Journal of biological chemistry. 280(14)
UDP-galactose 4′-epimerase (GALE) catalyzes the final step in the Leloir pathway of galactose metabolism, interconverting UDP-galactose and UDP-glucose. Unlike its Escherichia coli counterpart, mammalian GALE also interconverts UDP-N-acetylgalactos